IL2 and neuroblastoma: In the clinic, pediatric high-risk NB standard treatment includes chemotherapy and autologous stem cell transplantation followed by anti-GD2 therapy combined with granulocyte-macrophage colony-stimulating factor, interleukin-2 (IL-2), and 13-cis-retinoic acid.